📅Offer Date: 27 Jul 2021 – 29 Jul 2021
Data sourced from BSE & NSE · Last updated
Glenmark Life Sciences Limited IPO was subscribed 45.08x in total when bidding closed on 29 Jul 2021, with 37.30x in the QIB category, 125.62x in NII, 15.00x in retail. The issue ran from 27 Jul 2021 to 29 Jul 2021 at a price band of ₹695.00–₹720.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (15.00x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| QIBs | 42,42,379 | 15,82,40,737 | 37.30x |
| NIIs | 32,32,770 | 40,61,00,567 | 125.62x |
| Retail | 75,43,130 | 11,31,46,950 | 15.00x |
| Total | 1,50,18,279 | 67,70,24,017 | 45.08x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIBs | 305.45 | 11393.33 | 37.30x |
| NIIs | 232.76 | 29239.24 | 125.62x |
| Retail | 543.11 | 8146.58 | 15.00x |
| Total | 1081.32 | 48779.15 | 45.08x |
Values derived from share count × issue price (₹720.00)
Because Glenmark Life Sciences Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
BSE, NSE listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.